185 related articles for article (PubMed ID: 36765348)
1. Clinicopathological significance and prognostic role of LAG3 + tumor-infiltrating lymphocytes in colorectal cancer; relationship with sidedness.
Tavana S; Mokhtari Z; Sanei MH; Heidari Z; Dehghanian AR; Faghih Z; Rezaei M
Cancer Cell Int; 2023 Feb; 23(1):23. PubMed ID: 36765348
[TBL] [Abstract][Full Text] [Related]
2. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer.
Liu L; Long M; Su S; Wang L; Liu J
PeerJ; 2024; 12():e16747. PubMed ID: 38223758
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of immunoscore related markers in bladder cancer.
Ariafar A; Sanati A; Ahmadvand S; Shekarkhar G; Safaei A; Shayan Z; Faghih Z
BMC Urol; 2022 Aug; 22(1):133. PubMed ID: 36038861
[TBL] [Abstract][Full Text] [Related]
5. Density and location of CD3
Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
[TBL] [Abstract][Full Text] [Related]
6. CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome.
Mohammadi Y; Ahmadvand S; Mirtalebi M; Ashraf MJ; Khademi B; Ghaderi A
Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S133-S142. PubMed ID: 36319566
[TBL] [Abstract][Full Text] [Related]
7. Tim3 and PD-1 as a therapeutic and prognostic targets in colorectal cancer: Relationship with sidedness, clinicopathological parameters, and survival.
Mokhtari Z; Rezaei M; Sanei MH; Dehghanian A; Faghih Z; Heidari Z; Tavana S
Front Oncol; 2023; 13():1069696. PubMed ID: 37035199
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Infiltrating CD45RO
Ito N; Yamasaki S; Shintani T; Matsui K; Obayashi F; Koizumi K; Tani R; Yanamoto S; Okamoto T
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190149
[TBL] [Abstract][Full Text] [Related]
9. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
[TBL] [Abstract][Full Text] [Related]
11. High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma.
Rauser S; Langer R; Tschernitz S; Gais P; Jütting U; Feith M; Höfler H; Walch A
BMC Cancer; 2010 Nov; 10():608. PubMed ID: 21054833
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
13. Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer.
Chen R; Gong Y; Zou D; Wang L; Yuan L; Zhou Q
PeerJ; 2019; 7():e7804. PubMed ID: 31616592
[TBL] [Abstract][Full Text] [Related]
14. Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high-grade serous ovarian cancer.
Zhang G; Xu Q; Zhang X; Yang M; Wang Y; He M; Lu J; Liu H
Cancer Med; 2021 Jun; 10(12):3905-3918. PubMed ID: 33955198
[TBL] [Abstract][Full Text] [Related]
15. Differential gene expression of tumor-infiltrating CD8
Saleh R; Sasidharan Nair V; Toor SM; Taha RZ; Murshed K; Al-Dhaheri M; Khawar M; Petkar MA; Abu Nada M; Al-Ejeh F; Elkord E
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948653
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte-activated gene-3 (LAG3) protein expressed in tumor-infiltrating lymphocytes of colorectal cancer.
Xu J; Shen D; Zhang T; Wang J; De W; Zhang J
Pol J Pathol; 2021; 72(4):324-330. PubMed ID: 35308003
[TBL] [Abstract][Full Text] [Related]
17. Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance].
Saberzadeh-Ardestani B; Foster NR; Lee HE; Shi Q; Alberts SR; Smyrk TC; Sinicrope FA
Ann Oncol; 2022 Nov; 33(11):1159-1167. PubMed ID: 35963480
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CD8
Yin C; Okugawa Y; Yamamoto A; Kitajima T; Shimura T; Kawamura M; Tsujiura M; Okita Y; Ohi M; Toiyama Y
Oncol Lett; 2022 Jul; 24(1):212. PubMed ID: 35720505
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating CD45RO
Hu Z; Gu X; Zhong R; Zhong H
J Thorac Dis; 2018 Apr; 10(4):2089-2099. PubMed ID: 29850112
[TBL] [Abstract][Full Text] [Related]
20. Distinct role of tumor-infiltrating lymphocytes between synchronous and metachronous colorectal cancer.
Imazu Y; Matsuo Y; Hokuto D; Yasuda S; Yoshikawa T; Kamitani N; Yoshida C; Sasaki T; Sho M
Langenbecks Arch Surg; 2023 Feb; 408(1):72. PubMed ID: 36720759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
